Cumulus Neuroscience is a limited company established in Belfast, Ireland, focusing on the development and provision of medical-grade, in-home brain monitoring solutions. Founded in 2015, the company specializes in providing a sophisticated system for continuous, non-invasive monitoring of the central nervous system. Cumulus Neuroscience’s core service is the creation of a wearable device, utilizing advanced sensor technology, that collects real-time data on brain activity. This data is then transmitted securely to researchers and clinicians for analysis, supporting crucial CNS research and clinical trials. The company’s primary target market includes pharmaceutical companies, academic institutions, and clinical trial sites involved in neurological and psychiatric disorders. The company operates globally, with a strategic focus on Europe and North America. Cumulus Neuroscience employs a team of skilled neuroscientists, engineers, and software developers, and currently has a workforce of approximately 20 individuals. The company is actively pursuing international expansion, demonstrating a commitment to establishing a robust presence in key research hubs worldwide. The company’s SIC codes encompass Business and Domestic Software Development, and the company is classified as a Skilled Worker, holding a Worker (A) rating, reflecting its specialized technical expertise.

Cumulus Neuroscience is a limited company established in Belfast, Ireland, focusing on the development and provision of medical-grade, in-home brain monitoring solutions. Founded in 2015, the company specializes in providing a sophisticated system for continuous, non-invasive monitoring of the central nervous system. Cumulus Neuroscience’s core service is the creation of a wearable device, utilizing advanced sensor technology, that collects real-time data on brain activity. This data is then transmitted securely to researchers and clinicians for analysis, supporting crucial CNS research and clinical trials. The company’s primary target market includes pharmaceutical companies, academic institutions, and clinical trial sites involved in neurological and psychiatric disorders. The company operates globally, with a strategic focus on Europe and North America. Cumulus Neuroscience employs a team of skilled neuroscientists, engineers, and software developers, and currently has a workforce of approximately 20 individuals. The company is actively pursuing international expansion, demonstrating a commitment to establishing a robust presence in key research hubs worldwide. The company’s SIC codes encompass Business and Domestic Software Development, and the company is classified as a Skilled Worker, holding a Worker (A) rating, reflecting its specialized technical expertise.